---
title: "West Pharmaceutical Services Inc. Stock Underperforms Tuesday When Compared To Competitors"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286158273.md"
description: "West Pharmaceutical Services Inc. (WST) shares fell 3.17% to $312.07 on Tuesday, marking the second consecutive day of losses. The stock underperformed compared to competitors like Abbott Laboratories, Becton Dickinson, and Baxter International, which saw gains. WST is currently 5.68% below its 52-week high of $330.88 reached on May 11. The trading volume was 1.1 million, surpassing its 50-day average of 928,474."
datetime: "2026-05-12T21:04:18.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286158273.md)
  - [en](https://longbridge.com/en/news/286158273.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286158273.md)
---

# West Pharmaceutical Services Inc. Stock Underperforms Tuesday When Compared To Competitors

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of West Pharmaceutical Services Inc. (WST) slipped 3.17% to $312.07 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.11% to 49,760.56 and the S&P 500 Index falling 0.16% to 7,400.96.

This was the stock's second consecutive day of losses.

West Pharmaceutical Services Inc. closed 5.68% short of its 52-week high of $330.88, which the company reached on May 11th.

The stock underperformed when compared to some of its competitors Tuesday, as Abbott Laboratories (ABT) rose 2.17% to $84.35, Becton Dickinson & Co. (BDX) rose 3.05% to $147.51, and Baxter International Inc. (BAX) rose 2.05% to $17.89.

Trading volume (1.1 M) eclipsed its 50-day average volume of 928,474.

Data source: Dow Jones Market Data, FactSet. Data compiled May 12, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

05-12-26 1704ET

### Related Stocks

- [WST.US](https://longbridge.com/en/quote/WST.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md)
- [.SPX.US](https://longbridge.com/en/quote/.SPX.US.md)
- [ABT.US](https://longbridge.com/en/quote/ABT.US.md)
- [BDX.US](https://longbridge.com/en/quote/BDX.US.md)
- [BAX.US](https://longbridge.com/en/quote/BAX.US.md)

## Related News & Research

- [Radnor Capital Management LLC Has $1.65 Million Stock Holdings in West Pharmaceutical Services, Inc. $WST](https://longbridge.com/en/news/286893528.md)
- [West Pharma says operations recovering after cyberattack](https://longbridge.com/en/news/286600239.md)
- [Investors Await Damage Assessment After West Pharmaceutical Cyberattack](https://longbridge.com/en/news/286140541.md)
- [Corvus Pharmaceuticals presents Phase 1 soquelitinib data showing durable remissions, favorable safety](https://longbridge.com/en/news/286404245.md)
- [West Pharmaceutical Says Making Progress In Restoring Global Operations After Cyberattack](https://longbridge.com/en/news/286605804.md)